Novanta Inc. (NOVT): Price and Financial Metrics


Novanta Inc. (NOVT)

Today's Latest Price: $98.56 USD

0.04 (-0.04%)

Updated Feb 14 12:00am

Add NOVT to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

NOVT Stock Summary

  • With a price/earnings ratio of 76.85, Novanta Inc P/E ratio is greater than that of about 90.48% of stocks in our set with positive earnings.
  • Price to trailing twelve month operating cash flow for NOVT is currently 66.71, higher than 95.03% of US stocks with positive operating cash flow.
  • With a price/sales ratio of 5.33, Novanta Inc has a higher such ratio than 77.14% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Novanta Inc are MSTR, BRKR, SCL, ENTG, and AMSWA.
  • Visit NOVT's SEC page to see the company's official filings. To visit the company's web site, go to www.novanta.com.
NOVT Daily Price Range
NOVT 52-Week Price Range

NOVT Stock Price Chart More Charts


NOVT Price/Volume Stats

Current price $98.56 52-week high $99.48
Prev. close $98.60 52-week low $69.31
Day low $98.09 Volume 86,100
Day high $99.48 Avg. volume 98,690
50-day MA $93.00 Dividend yield N/A
200-day MA $85.71 Market Cap 3.46B

Novanta Inc. (NOVT) Company Bio


Novanta Inc. designs, develops, manufactures, and sells precision photonic and motion control components, and subsystems to original equipment manufacturers in the medical equipment and advanced industrial technology markets. The company operates through three segments: Laser Products, Vision Technologies, and Precision Motion. The company was founded in 1968 and is based in Bedford, Massachusetts.

NOVT Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$98.56$7.02-93%

We started the process of determining a valid price forecast for Novanta Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Novanta Inc ranked in the 10st percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 93%. As for the metrics that stood out in our discounted cash flow analysis of Novanta Inc, consider:

  • The company's debt burden, as measured by earnings divided by interest payments, is 6.62 -- which is good for besting 60.21% of its peer stocks (US stocks in the Technology sector with positive cash flow).
  • Its compound free cash flow growth rate, as measured over the past 5.5 years, is -0.03% -- higher than only 24.11% of stocks in our DCF forecasting set.
  • The business' balance sheet suggests that 7% of the company's capital is sourced from debt; this is greater than merely 20.84% of the free cash flow producing stocks we're observing.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-93%
1%-93%
2%-93%
3%-93%
4%-93%
5%-93%

GWRE, HBB, TTLO, CTG, and DOCU can be thought of as valuation peers to NOVT, in the sense that they are in the Technology sector and have a similar price forecast based on DCF valuation.


NOVT Latest News Stream


Event/TimeNews Detail
Loading, please wait...

NOVT Latest Social Stream


Loading social stream, please wait...

View Full NOVT Social Stream

NOVT Price Returns

1-mo 0.94%
3-mo 18.46%
6-mo 28.57%
1-year 31.54%
3-year 302.29%
5-year 619.94%
YTD 11.44%
2019 40.38%
2018 26.00%
2017 138.10%
2016 54.19%
2015 -7.47%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5983 seconds.